Related Experiment Video
Updated: Nov 27, 2025
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.6K
Micro-RNAs signatures in papillary thyroid carcinoma.
Nicholas Mastronikolis1, Evangelos Tsiambas, Dimitrios Roukas
1Dept of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Greece.
Summary
Novel micro-RNAs (miRs) show promise as biomarkers for thyroid carcinoma. This review categorizes miRs by their up- or down-regulation in papillary thyroid cancer, aiding molecular discrimination for treatment and prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Micro-RNAs (miRs) are short, non-coding RNAs regulating gene expression.
- Deregulation of miRs is implicated in various cancers, including thyroid carcinoma.
- miRs can exhibit a dual role in oncogenesis, acting as either tumor suppressors or oncogenes.
Purpose of the Study:
- To review the role of specific micro-RNAs in papillary thyroid carcinoma (PTC).
- To categorize miRs based on their expression levels (up- or down-regulated) in PTC.
- To explore the potential of miRs as molecular biomarkers for PTC patient stratification.
Main Methods:
- Literature review of studies investigating micro-RNAs in thyroid cancer.
- Analysis of micro-RNA expression patterns in papillary thyroid carcinoma.
- Categorization of identified miRs by their up-regulation or down-regulation status.
Main Results:
- Specific micro-RNAs are frequently dysregulated in papillary thyroid carcinoma.
- The expression status (up- or down-regulated) of miRs varies, suggesting context-dependent roles.
- Identified miRs contribute to the molecular signature of PTC.
Conclusions:
- Micro-RNAs are significant potential biomarkers for papillary thyroid carcinoma.
- Understanding miR dysregulation aids in molecular classification and may inform treatment strategies.
- Further research into specific miRs could improve patient prognosis and therapeutic approaches.
